XML 63 R114.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidating Financial Information (Details 2) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Jan. 01, 2012
Jan. 02, 2011
Cash Flow from Operating Activities:      
Cash (used in) provided by operating activities - continuing operations $ 255,187 $ 185,741 $ 125,472
Cash (used in) provided by operating activities - discontinued operations 9,053 3,371 4,418
Net cash provided by operating activities of continuing operations 264,240 189,112 129,890
Cash Flow from Investing Activities:      
Acquisition of ownership interests in MCF (35,154) 0 0
Proceeds from RTS divestiture 33,253 0 0
Acquisition of BI and Cornell, cash consideration, net of cash acquired   (409,607) (260,255)
Proceeds from sale of property and equipment 65 1,483 480
Proceeds from sale of assets held for sale 5,641 7,121 0
Change in restricted cash and investments 51,189 (9,503) (11,184)
Capital expenditures (107,549) (222,033) (94,691)
Cash used in investing activities - continuing operations (52,555) (632,539) (365,650)
Cash (used in) provided by investing activities - discontinued operations (2,761) (3,002) (2,611)
Net cash used in investing activities (55,316) (635,541) (368,261)
Cash Flow from Financing Activities:      
Proceeds from long term debt 358,000 835,395 726,000
Income tax benefit of equity compensation 621 465 3,926
Payment of make-whole provision and other fees for early extinguishment of debt (14,861) 0 0
Distribution to noncontrolling interests (5,758) (4,012) 0
Payments for purchase of treasury shares (8,666) (74,982) (80,000)
Debt issuance costs (1,398) (15,462) (8,400)
Payments on long-term debt (456,485) (289,832) (397,445)
Proceeds from the exercise of stock options 9,276 2,446 6,695
Cash dividends paid 102,435 0 0
Proceeds from reissuance of treasury stock in connection with ESPP 460 0 0
Payments for retirement of common stock (1,036) 0 (7,078)
Net cash provided by (used in) financing activities (222,282) 454,018 243,698
Effect of Exchange Rate Changes on Cash and Cash Equivalents 1,735 (2,299) 4,169
Net Increase (Decrease) in Cash and Cash Equivalents (11,623) 5,290 9,496
Cash and Cash Equivalents, beginning of period 43,378 38,088 28,592
Cash and Cash Equivalents, end of period 31,755 43,378 38,088
The GEO Group Inc. [Member]
     
Cash Flow from Operating Activities:      
Cash (used in) provided by operating activities - continuing operations 107,116 173,438 79,469
Cash (used in) provided by operating activities - discontinued operations 3,250 3,475 (3,818)
Net cash provided by operating activities of continuing operations 110,366 176,913 75,651
Cash Flow from Investing Activities:      
Acquisition of ownership interests in MCF 0    
Proceeds from RTS divestiture 29,653    
Acquisition of BI and Cornell, cash consideration, net of cash acquired   (409,607) (260,255)
Proceeds from sale of property and equipment 0 0 0
Proceeds from sale of assets held for sale 0 0  
Change in restricted cash and investments 0 0 0
Capital expenditures (61,425) (191,642) (79,062)
Cash used in investing activities - continuing operations (31,772) (601,249) (339,317)
Cash (used in) provided by investing activities - discontinued operations 211 (696) (954)
Net cash used in investing activities (31,561) (601,945) (340,271)
Cash Flow from Financing Activities:      
Proceeds from long term debt 358,000 782,247 726,000
Income tax benefit of equity compensation 621 465 3,926
Payment of make-whole provision and other fees for early extinguishment of debt 0    
Distribution to noncontrolling interests 0 0  
Payments for purchase of treasury shares 8,666 (74,982) (80,000)
Debt issuance costs (1,360) (15,462) (8,400)
Payments on long-term debt 343,987 (257,210) (386,285)
Proceeds from the exercise of stock options 9,276 2,446 6,695
Cash dividends paid (102,435)    
Proceeds from reissuance of treasury stock in connection with ESPP 460    
Payments for retirement of common stock (1,036)   (7,078)
Net cash provided by (used in) financing activities (89,127) 437,504 254,858
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 0 0
Net Increase (Decrease) in Cash and Cash Equivalents (10,322) 12,472 (9,762)
Cash and Cash Equivalents, beginning of period 15,086 2,614 12,376
Cash and Cash Equivalents, end of period 4,764 15,086 2,614
Combined Subsidiary Guarantors [Member]
     
Cash Flow from Operating Activities:      
Cash (used in) provided by operating activities - continuing operations 62,330 18,834 6,542
Cash (used in) provided by operating activities - discontinued operations 26,430 7,026 9,558
Net cash provided by operating activities of continuing operations 88,760 25,860 16,100
Cash Flow from Investing Activities:      
Acquisition of ownership interests in MCF (35,154)    
Proceeds from RTS divestiture 0    
Acquisition of BI and Cornell, cash consideration, net of cash acquired   0 0
Proceeds from sale of property and equipment 65 1,450 480
Proceeds from sale of assets held for sale 5,641 7,121  
Change in restricted cash and investments 0 0 0
Capital expenditures (42,406) (28,266) (14,385)
Cash used in investing activities - continuing operations (71,854) (19,695) (13,905)
Cash (used in) provided by investing activities - discontinued operations (1,820) (1,973) (1,369)
Net cash used in investing activities (73,674) (21,668) (15,274)
Cash Flow from Financing Activities:      
Proceeds from long term debt 0 0 0
Income tax benefit of equity compensation 0 0 0
Payment of make-whole provision and other fees for early extinguishment of debt (14,861)    
Distribution to noncontrolling interests 0 0  
Payments for purchase of treasury shares 0   0
Debt issuance costs 0 0 0
Payments on long-term debt 1,400 (1,275) (720)
Proceeds from the exercise of stock options 0 0 0
Cash dividends paid 0    
Proceeds from reissuance of treasury stock in connection with ESPP 0    
Payments for retirement of common stock 0   0
Net cash provided by (used in) financing activities (16,261) (1,275) (720)
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 0 0
Net Increase (Decrease) in Cash and Cash Equivalents (1,175) 2,917 106
Cash and Cash Equivalents, beginning of period 3,092 175 69
Cash and Cash Equivalents, end of period 1,917 3,092 175
Combined Non-Guarantor Subsidiaries [Member]
     
Cash Flow from Operating Activities:      
Cash (used in) provided by operating activities - continuing operations 85,741 (6,531) 39,461
Cash (used in) provided by operating activities - discontinued operations (20,627) (7,130) (1,322)
Net cash provided by operating activities of continuing operations 65,114 (13,661) 38,139
Cash Flow from Investing Activities:      
Acquisition of ownership interests in MCF 0    
Proceeds from RTS divestiture 3,600    
Acquisition of BI and Cornell, cash consideration, net of cash acquired   0 0
Proceeds from sale of property and equipment 0 33   
Change in restricted cash and investments 51,189 (9,503) (11,184)
Capital expenditures (3,718) (2,125) (1,244)
Cash used in investing activities - continuing operations 51,071 (11,595) (12,428)
Cash (used in) provided by investing activities - discontinued operations (1,152) (333) (288)
Net cash used in investing activities 49,919 (11,928) (12,716)
Cash Flow from Financing Activities:      
Proceeds from long term debt 0 53,148 0
Income tax benefit of equity compensation 0 0 0
Payment of make-whole provision and other fees for early extinguishment of debt 0    
Distribution to noncontrolling interests 5,758 (4,012)  
Payments for purchase of treasury shares 0 0 0
Debt issuance costs (38) 0 0
Payments on long-term debt 111,098 (31,347) (10,440)
Proceeds from the exercise of stock options 0 0 0
Cash dividends paid 0    
Proceeds from reissuance of treasury stock in connection with ESPP 0    
Payments for retirement of common stock 0   0
Net cash provided by (used in) financing activities (116,894) 17,789 (10,440)
Effect of Exchange Rate Changes on Cash and Cash Equivalents 1,735 (2,299) 4,169
Net Increase (Decrease) in Cash and Cash Equivalents (126) (10,099) 19,152
Cash and Cash Equivalents, beginning of period 25,200 35,299 16,147
Cash and Cash Equivalents, end of period $ 25,074 $ 25,200 $ 35,299